Ibogaine Retreat in
Mexico

Initial Consultation

A 45-minute clinical consultation with our medical team. We review your history, goals, medications, and health status to determine whether an ibogaine retreat is clinically appropriate for you and which protocol best fits your situation.

Medical Screening & Clearance

Cardiac screening including EKG, comprehensive blood work, and psychiatric evaluation. If you have a home physician, we coordinate with them. Patients with contraindicated conditions are referred to appropriate care rather than accepted inappropriately.

Preparation Phase

Dietary guidelines, medication adjustments (under physician supervision), psychoeducation about the ibogaine experience, intention-setting, and pre-treatment therapy. A well-prepared patient consistently achieves better outcomes. We invest in this phase.

Arrival in Cozumel

Our team coordinates your arrival at Cancun International Airport, ferry transfer to Cozumel, and ground transport to our facility. Your first days in Cozumel include final screening, acclimation, and preparation sessions before your ibogaine retreat session.

Ibogaine Treatment Session

Administered in a private medical suite with continuous cardiac monitoring, physician presence, and registered nursing support. The acute phase lasts 12 to 36 hours. You rest. You process. Your care team is beside you the entire time.

In-Retreat Integration

Days 2 through 7 post-treatment are the integration core of your ibogaine retreat. Daily psychotherapy, somatic grounding, nutrition, movement, and time in nature. This is where insights become commitments and commitments become new neural pathways.

Ongoing Aftercare at Home

Remote weekly psychotherapy, psychiatric oversight, medication management, and alumni community access for 6 to 12 months after your return. The ibogaine retreat does not end when you board the ferry — it continues until lasting change is anchored.

Yes. Ibogaine does not appear on Mexico's controlled substances schedule (Lista I–IV) and can be legally administered by licensed medical professionals in a clinical setting. U.S. and Canadian citizens traveling to Mexico for an ibogaine retreat incur no domestic legal consequences. You are not breaking any law in your home country by receiving treatment abroad. We recommend consulting a lawyer familiar with your jurisdiction if you have specific concerns.

Safety at an ibogaine retreat depends on four non-negotiables: a board-certified physician who can interpret cardiac data and manage emergencies, comprehensive pre-treatment cardiac screening and blood work, pharmaceutical-grade ibogaine with verified purity and individualized dosing, and continuous monitoring throughout the active phase. MindScape provides all four. The majority of ibogaine-related fatalities in the medical literature occurred in unsupervised or inadequately monitored settings — not in properly structured clinical retreats.

The primary indications for an ibogaine retreat are opioid and substance addiction (heroin, fentanyl, methadone, opioid painkillers, cocaine, alcohol), treatment-resistant depression, PTSD and complex trauma, traumatic brain injury, and anxiety disorders that have not responded to conventional treatment. Ibogaine's mechanism — upregulation of GDNF, BDNF, and serotonergic reset combined with deep introspective capacity — makes it uniquely suited to conditions where conventional medicine has reached its limits.

Ceremonial retreats use a spiritual or indigenous framework to guide the ibogaine experience. MindScape is a medical facility. We have a board-certified physician on-site, not a shaman. We use pharmaceutical-grade compounds, not artisanal preparations. We perform EKGs and blood panels, not blessings. This is not a criticism of ceremonial approaches — it is a description of what clinical ibogaine retreats require when the patient has an active addiction, a cardiac history, a psychiatric diagnosis, or any medical complexity whatsoever.

Most ibogaine retreat programs at MindScape run 7 to 10 days in Cozumel. This includes 1 to 2 pre-treatment preparation days, the treatment session (12 to 36 hours), and 4 to 7 days of integration. Patients with severe addiction, complex medical history, or those combining ibogaine with 5-MeO-DMT may opt for 10 to 14 day programs. After returning home, you receive 6 to 12 months of remote aftercare support.

Published clinical research and MindScape's own outcomes data show 70 to 80 percent of patients achieve sustained abstinence (6 months or longer) when ibogaine treatment is combined with structured aftercare. Success rates without aftercare are substantially lower. This is why our program includes 6 to 12 months of remote psychotherapy rather than offering treatment as a standalone event. An ibogaine retreat is not a cure — it is a powerful catalyst that requires ongoing integration support.

Patients with uncorrectable QTc prolongation, severe cardiac disease, certain arrhythmias, active untreated psychosis, acute bipolar mania, or recent use of certain medications (particularly methadone at high doses, some antidepressants, and QT-prolonging drugs) may not be cleared for an ibogaine retreat. We conduct thorough medical screening precisely to identify these contraindications before treatment begins. A refusal to treat is sometimes the most important clinical decision we make.

It requires careful management. High-dose methadone significantly extends the QTc interval, and combining it with ibogaine without a proper taper creates serious cardiac risk. We work with patients on methadone and buprenorphine (Suboxone) through a supervised taper protocol coordinated with our medical team prior to arrival. Most patients can transition to a safe pre-treatment baseline with proper guidance. We do not accept patients who have not completed the required taper.

Ibogaine HCL is a purified single-alkaloid extract that produces a rapid-onset, high-intensity flood experience typically lasting 12 to 24 hours. Ibogaine TA (Total Alkaloid) retains all 12 naturally occurring alkaloids from the iboga root, including ibogamine, ibogaline, and tabernanthine. TA provides a gentler onset, deeper emotional resonance, and additional neuroprotective and anti-inflammatory benefits not present in HCL alone. MindScape uses TA booster sessions prior to the HCL flood dose — a dual-form protocol that produces outcomes consistently superior to either form in isolation.

Contact us through our screening form at /contact-mindscape-retreat. A member of our clinical intake team will review your submission and schedule a consultation call within 48 hours. We assess medical history, substances, medications, diagnoses, and goals. If you are a candidate, we move to formal medical screening and program planning. We answer every question you have before any commitment is made — an ibogaine retreat is a significant decision and you deserve complete clarity going in.